Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday

Palatin Technologies, Inc.
(NYSE Amex Equities : PTN)

( )
PTN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PTN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.28%155.001.1%$504.59m
GILDGilead Sciences, Inc.
-0.40%64.300.9%$489.93m
REGNRegeneron Pharmaceuticals, Inc.
0.00%455.702.7%$466.21m
CELGCelgene Corporation
0.00%116.741.1%$419.11m
BIIBBiogen Inc.
-0.06%252.811.2%$387.42m
ALXNAlexion Pharmaceuticals, Inc.
0.86%99.351.9%$353.97m
INCYIncyte Corporation
0.00%138.412.6%$272.84m
VRTXVertex Pharmaceuticals Incorporated
0.00%118.601.9%$199.99m
PBYIPuma Biotechnology, Inc.
-1.60%76.8021.1%$199.46m
ILMNIllumina, Inc.
0.00%173.763.5%$196.01m
EXASExact Sciences Corporation
0.00%33.1928.0%$151.08m
AAgilent Technologies, Inc.
0.00%59.311.5%$135.90m
TSROTESARO, Inc.
0.00%153.1914.7%$110.52m
BMRNBioMarin Pharmaceutical Inc.
0.00%87.334.4%$104.59m
KITEKite Pharma, Inc.
0.00%74.9116.1%$102.44m

Company Profile

Palatin Technologies, Inc. is a biopharmaceutical company which develops targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product in development is bremelanotide for the treatment of female sexual dysfunction. It is also developing an inhalation formulation of peptide mimetic natriuretic peptide receptor A-agonist, for treatment of cardiovascular and pulmonary indications. The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.